press release | Peptide Development Services | AmbioPharm

AmbioPharm Appoints Industry Veteran Brian Gregg as CEO

October 2, 2023

AmbioPharm Provides an Update on Shanghai Campus Expansion and Resumption of Customer Visits

April 25, 2023

AmbioPharm to Host a Sustainable Peptide Manufacturing Workshop at Biologics 2023

March 21, 2023

Ariceum Therapeutics and AmbioPharm Enter Strategic Manufacturing and Supply Partnership

October 27, 2022

AmbioPharm and ONL Therapeutics logos

AmbioPharm Supports ONL Therapeutics with Peptide Manufacturing to Prepare for IND Application for Phase 2 Study

July 12, 2022

CEM Corporation and AmbioPharm Form U.S. Partnership for GMP Peptide Production

CEM Corporation and AmbioPharm Form U.S. Partnership for GMP Peptide Production

September 14, 2021

AmbioPharm Inc. Working with University of California Davis to Develop Non-Opioid Peptide-Based Pain Therapeutics

July 20, 2021

AmbioPharm Inc. Announces New Shanghai Campus Opening and European Executive Team Members

January 7, 2021

SETTING A NEW STANDARD

For Peptide API Manufacturing and Services

Have a Peptide project?

SUBMIT YOUR REQUIREMENTS